CJC 1295 with DAC (drug affinity complex) 5mg is formulated for precise research applications. At Ultra Peps, we prioritize consistency, reliability, and research-focused handling standards.
Growth hormone signaling investigations
Drug Affinity Complex (DAC) modification allows the peptide to extend its half-life and duration
Trusted research supplier
Fast order processing
⚠️ Buy more and Save — price-per-vial table below. Quantity pricing can’t be combined with coupons; applying a coupon removes the quantity discount automatically.
CJC-1295 with DAC 5mg is a synthetic growth hormone-releasing hormone (GHRH) analog designed to interact with GHRH receptors and influence growth hormone signaling pathways. Additionally, the inclusion of a Drug Affinity Complex (DAC) extends the peptide’s activity profile, allowing researchers to investigate prolonged receptor activation and sustained endocrine signaling.
Due to its extended half-life, CJC-1295 with DAC is frequently utilized in laboratory studies involving hormone regulation, growth factor signaling, receptor activity, and peptide pharmacology. Furthermore, researchers commonly use this compound to examine long-duration endocrine communication pathways and the biological effects associated with sustained receptor engagement. As a result, CJC-1295 with DAC remains a valuable research tool in endocrine and growth factor-related investigations.
Mode of Action
How CJC-1295 with DAC Is Modeled to Work
CJC with DAC is a combination of 2 peptides. It is a growth hormone releasing hormone (GHRH) that is studied for one side of the pituitary gland. It does this in order to produce growth hormone. GHRH comes from the hypothalamus. Its pulsatile release from the hypothalamus triggers a release of GH from the pituitary gland.
GHRH has a very short half-life of only a few minutes (half-life = the time required to remove half of the substance from the blood). For instance, the shorter the half-life, the more rapidly the substance disappears from the body, and the less its effect on the body.
In addition, the first 29 amino acids of GHRH is the active segment. They are available as a manufactured peptide called Sermorelin. Sermorelin increases its half-life to 30 minutes which is CJC 1295. CJC 1295 then added DAC (Drug Affinity Complex) to it. DAC binds to a blood protein called albumin, which increases its half-life to 8 days which is CJC 1295 + DAC.
Therefore, the longer half-life from the DAC binding to albumin means a relatively constant blood level provides a constant stimulus for GH release from the pituitary through the GHRH receptor, which is not physiological. In short, This can decrease the GH pulse amplitude which will result in decreased GH tissue stimulation.
Illustrative animation of pathways referenced in preclinical / in-vitro literature — not a claim of clinical effect.
GHRH Receptor Binding
Framed as the primary receptor interaction studied for CJC-1295 with DAC — binding GHRH receptors on pituitary somatotroph cells.
DAC–Albumin Binding
Referenced in studies examining how the Drug Affinity Complex (DAC) binds circulating albumin to extend the peptide’s half-life to roughly eight days.
Sustained GH Release
Associated with research into constant-level GHRH-receptor stimulation, studied for its relationship to reduced GH pulse amplitude relative to natural pulsatile release.
Chemical Details
Structure & Properties
Property
Value
Chemical Name
CJC-1295 with DAC / Tetrasubstituted GRF(1-29) with Drug Affinity Complex
Researchers commonly investigate CJC-1295 with DAC in studies involving sustained growth hormone signaling, receptor pharmacology, and long-duration endocrine research models.
Controlled Laboratory Analysis
Framed as a standard laboratory-analysis reference point in studies handling CJC-1295 with DAC under controlled experimental conditions.
Growth Hormone Signaling Investigations
Referenced in studies examining sustained GHRH-receptor stimulation and its downstream effects on growth hormone secretion.
IGF-1 Pathway Research
Associated with research into growth hormone-driven IGF-1 signaling and its role in broader growth factor pathways.
Endocrine Communication Studies
Explored in studies of long-duration endocrine signaling and hormone-pathway communication.
GHRH Receptor Activity Research
Investigated in receptor-activity research examining GHRH receptor engagement on pituitary somatotroph cells.
Extended Half-Life & Sustained Engagement Research
Framed as a reference compound for studying DAC-albumin binding and its effect on prolonged receptor activation versus natural pulsatile release.
Related Research
Related Research Compounds
The compounds below fall into two groups: direct GHRH-pathway analogs, followed by GH secretagogues that don’t share the same receptor mechanism but are studied for producing similar downstream growth-hormone outcomes.
Short-acting (about 30 minutes) and researched for GH pulses rather than sustained elevation, often paired with Ipamorelin. Where “CJC No DAC” is studied as a natural GH-rhythm enhancer, “CJC with DAC” is studied for long GH elevation — this is the closest comparison without the extended half-life.
Very similar to CJC-1295 No DAC and shorter-acting; useful for long-term GH/IGF-1 research, though not as strong as CJC with DAC while remaining close in mechanism.
A GH secretagogue often researched alongside CJC-1295, showing strong synergy with the No DAC version — a similar outcome achieved through a different receptor (GHSR).
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law. This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
CJC-1295 with DAC / Tetrasubstituted GRF(1-29) with Drug Affinity Complex
Molecular Formula
C165H269N47O46
Molecular Weight
3647.30 g/mol
Sequence
Modified GHRH(1-29) with a DAC conjugation group
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law.This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Each unit is prepared with attention to consistency. Packaging is sealed and reinforced to protect shipment integrity. In addition, we offer Protection Coverage at checkout as an additional option which covers lost or damaged packages ($3.99). We’ll re-ship or refund eligible orders once confirmed. For additional information please visit our Shipping Policy and tracking Info Page
We ship USPS Priority only
Ships same day M-F (before 4pm est cutoff)
Orders placed on a Federal holiday or weekend will be delivered on the next business day
Free shipping on orders over $150. This offer will be available based on post-discount order amount
Signature confirmation is offered at checkout for $19.99
Tracking & Insurance (up to $100 via USPS) is included
Property
Value
Chemical Name
CJC-1295 with DAC / Tetrasubstituted GRF(1-29) with Drug Affinity Complex
Molecular Formula
C165H269N47O46
Molecular Weight
3647.30 g/mol
Sequence
Modified GHRH(1-29) with a DAC conjugation group
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law.This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
I. RESEARCH USE ONLY: Products are sold strictly for laboratory research and in-vitro testing, not for human or animal use. II. ASSUMPTION OF RISK: You assume all risk associated with these chemicals. III. LIABILITY: You agree to indemnify BCUltra LLC for any misuse, including human consumption. IV. COMPLIANCE: You certify you are 21+ & will handle these peptides & chems per all applicable law.
0 items
New here? Take 10% OFF your first order with code WELCOME10 at checkout.
CJC 1295 with DAC 5mg
$43.99
CJC 1295 with DAC (drug affinity complex) 5mg is formulated for precise research applications. At Ultra Peps, we prioritize consistency, reliability, and research-focused handling standards.
⚠️ Buy more and Save — price-per-vial table below. Quantity pricing can’t be combined with coupons; applying a coupon removes the quantity discount automatically.
🔒Payments Accepted
Product images are for illustration purposes only.
Description
Overview
CJC-1295 with DAC Research Compound
CJC-1295 with DAC 5mg is a synthetic growth hormone-releasing hormone (GHRH) analog designed to interact with GHRH receptors and influence growth hormone signaling pathways. Additionally, the inclusion of a Drug Affinity Complex (DAC) extends the peptide’s activity profile, allowing researchers to investigate prolonged receptor activation and sustained endocrine signaling.
Due to its extended half-life, CJC-1295 with DAC is frequently utilized in laboratory studies involving hormone regulation, growth factor signaling, receptor activity, and peptide pharmacology. Furthermore, researchers commonly use this compound to examine long-duration endocrine communication pathways and the biological effects associated with sustained receptor engagement. As a result, CJC-1295 with DAC remains a valuable research tool in endocrine and growth factor-related investigations.
Mode of Action
How CJC-1295 with DAC Is Modeled to Work
CJC with DAC is a combination of 2 peptides. It is a growth hormone releasing hormone (GHRH) that is studied for one side of the pituitary gland. It does this in order to produce growth hormone. GHRH comes from the hypothalamus. Its pulsatile release from the hypothalamus triggers a release of GH from the pituitary gland.
GHRH has a very short half-life of only a few minutes (half-life = the time required to remove half of the substance from the blood). For instance, the shorter the half-life, the more rapidly the substance disappears from the body, and the less its effect on the body.
In addition, the first 29 amino acids of GHRH is the active segment. They are available as a manufactured peptide called Sermorelin. Sermorelin increases its half-life to 30 minutes which is CJC 1295. CJC 1295 then added DAC (Drug Affinity Complex) to it. DAC binds to a blood protein called albumin, which increases its half-life to 8 days which is CJC 1295 + DAC.
Therefore, the longer half-life from the DAC binding to albumin means a relatively constant blood level provides a constant stimulus for GH release from the pituitary through the GHRH receptor, which is not physiological. In short, This can decrease the GH pulse amplitude which will result in decreased GH tissue stimulation.
Illustrative animation of pathways referenced in preclinical / in-vitro literature — not a claim of clinical effect.
GHRH Receptor Binding
Framed as the primary receptor interaction studied for CJC-1295 with DAC — binding GHRH receptors on pituitary somatotroph cells.
DAC–Albumin Binding
Referenced in studies examining how the Drug Affinity Complex (DAC) binds circulating albumin to extend the peptide’s half-life to roughly eight days.
Sustained GH Release
Associated with research into constant-level GHRH-receptor stimulation, studied for its relationship to reduced GH pulse amplitude relative to natural pulsatile release.
Chemical Details
Structure & Properties
2D ANIMATION
Illustrative molecular-assembly animation (generic structural reference).
Research Scope
What CJC-1295 with DAC Is Researched For
Researchers commonly investigate CJC-1295 with DAC in studies involving sustained growth hormone signaling, receptor pharmacology, and long-duration endocrine research models.
Framed as a standard laboratory-analysis reference point in studies handling CJC-1295 with DAC under controlled experimental conditions.
Referenced in studies examining sustained GHRH-receptor stimulation and its downstream effects on growth hormone secretion.
Associated with research into growth hormone-driven IGF-1 signaling and its role in broader growth factor pathways.
Explored in studies of long-duration endocrine signaling and hormone-pathway communication.
Investigated in receptor-activity research examining GHRH receptor engagement on pituitary somatotroph cells.
Framed as a reference compound for studying DAC-albumin binding and its effect on prolonged receptor activation versus natural pulsatile release.
Related Research
Related Research Compounds
The compounds below fall into two groups: direct GHRH-pathway analogs, followed by GH secretagogues that don’t share the same receptor mechanism but are studied for producing similar downstream growth-hormone outcomes.
MOD GRF 1-29 (a.k.a. CJC-1295 No DAC)
Short-acting (about 30 minutes) and researched for GH pulses rather than sustained elevation, often paired with Ipamorelin. Where “CJC No DAC” is studied as a natural GH-rhythm enhancer, “CJC with DAC” is studied for long GH elevation — this is the closest comparison without the extended half-life.
Tesamorelin
A stronger GHRH analog studied as a clinically more potent pharmaceutical version, associated with a greater increase in IGF-1.
Sermorelin
Very similar to CJC-1295 No DAC and shorter-acting; useful for long-term GH/IGF-1 research, though not as strong as CJC with DAC while remaining close in mechanism.
Ipamorelin
A GH secretagogue often researched alongside CJC-1295, showing strong synergy with the No DAC version — a similar outcome achieved through a different receptor (GHSR).
GHRP-2
A strong GH releaser that works well with CJC peptides, studied as stronger but less selective than Ipamorelin.
GHRP-6
A very potent GH releaser with GH effects similar to CJC-1295 but acting on a different pathway.
Hexarelin
The strongest GH secretagogue in this comparison set, studied for producing significant GH spikes that desensitize more quickly.
Selected Literature
Published Research
Further Reading
This Product Is For Research Only
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law. This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law.This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.
Additional information
Solid (Powder)
White
5mg
peptide analogue of growth hormone-releasing hormone (GHRH)
Research Peptide
Ultra Peps
Each unit is prepared with attention to consistency. Packaging is sealed and reinforced to protect shipment integrity. In addition, we offer Protection Coverage at checkout as an additional option which covers lost or damaged packages ($3.99). We’ll re-ship or refund eligible orders once confirmed. For additional information please visit our Shipping Policy and tracking Info Page
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law.This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.
Certificate of Analysis
View the Certificate of Analysis for this batch, provided by our testing lab.
Download COA (PDF)
You may also like…
Hexarelin 5mg
$39.99 Add to cartIpamorelin 5mg
$32.99 Add to cartGHRP 2 5mg
$19.99 Add to cartGHRP 6 5mg
$19.99 Add to cartTesamorelin 2mg
$37.99 Add to cartCJC 1295 NO DAC 5mg
$36.99 Add to cartSermorelin 2mg
$34.99 Add to cartRelated products
DSIP (Delta Sleep Inducing Peptide) 5mg
$32.99 Add to cartSelank 10mg
$41.99 Add to cartGHK-Cu 100mg
$145.99 Add to cartPT 141 10mg
$37.99 Add to cart